NIAID Clinical Trial Implementation (U01) Cooperative Agreement
The summary for the NIAID Clinical Trial Implementation (U01) Cooperative Agreement grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
NIAID Clinical Trial Implementation (U01) Cooperative Agreement: Beginning with the May 1, 2006 receipt date for AIDS applications and the June 1, 2006 receipt date for non-AIDS applications, NIAID will accept, peer review, and consider for funding applications for implementation of investigator-initiated clinical trials only from NIAID Clinical Trial Planning (R34) grant awardees (See PAR-05-112 for information on NIAID Clinical Trial Planning Grants). Each clinical trial implementation application will use the PHS 398 grant application with special instructions and will include a copy of the Institutional Review Board (IRB) approved study protocol, investigators brochure or equivalent, and a manual of operations or equivalent. These documents must meet all National Institutes of Health (NIH), Food and Drug Administration (FDA), and Office of Human Research Protections (OHRP) requirements. All awards will be made as cooperative agreements. In order not to delay the initiation of the clinical trial, the peer review ! and award of the clinical trial implementation grant will be completed within four months of the receipt of the application.
|Federal Grant Title:||NIAID Clinical Trial Implementation (U01) Cooperative Agreement|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||PAR-05-113|
|Type of Funding:||Cooperative Agreement|
|CFDA Descriptions:||Allergy, Immunology and Transplantation Research 93.856 Microbiology and Infectious Diseases Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||May 07, 2009 Multiple Receipt Dates - See Link to|
|Posted Date:||May 19, 2005|
|Creation Date:||Dec 02, 2008|
|Archive Date:||Dec 03, 2008|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts State governments Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Special district governments For profit organizations other than small businesses Small businesses Native American tribal governments (Federally recognized) Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are eligible to apply. Institutions must be in compliance with U.S. laws and regulations and DHHS and NIH policies in effect at the time of grant award and during the period of performance of the research.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...